196 related articles for article (PubMed ID: 33536753)
1. Honokiol/Magnolol-Loaded Self-Assembling Lecithin-Based Mixed Polymeric Micelles (
Lin HL; Cheng WT; Chen LC; Ho HO; Lin SY; Hsieh CM
Int J Nanomedicine; 2021; 16():651-665. PubMed ID: 33536753
[TBL] [Abstract][Full Text] [Related]
2. Development and Characterization of Lecithin-based Self-assembling Mixed Polymeric Micellar (saMPMs) Drug Delivery Systems for Curcumin.
Chen LC; Chen YC; Su CY; Wong WP; Sheu MT; Ho HO
Sci Rep; 2016 Nov; 6():37122. PubMed ID: 27848996
[TBL] [Abstract][Full Text] [Related]
3. Improved oral bioavailability of magnolol by using a binary mixed micelle system.
Ding P; Shen H; Wang J; Ju J
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):668-674. PubMed ID: 30183380
[TBL] [Abstract][Full Text] [Related]
4. Preparation of honokiol nanoparticles by liquid antisolvent precipitation technique, characterization, pharmacokinetics, and evaluation of inhibitory effect on HepG2 cells.
Wu W; Wang L; Wang L; Zu Y; Wang S; Liu P; Zhao X
Int J Nanomedicine; 2018; 13():5469-5483. PubMed ID: 30271141
[TBL] [Abstract][Full Text] [Related]
5. Enhanced oral bioavailability of magnolol via mixed micelles and nanosuspensions based on Soluplus
Li G; Lu Y; Fan Y; Ning Q; Li W
Drug Deliv; 2020 Dec; 27(1):1010-1017. PubMed ID: 32631085
[TBL] [Abstract][Full Text] [Related]
6. Physical and Pharmacokinetic Characterizations of trans-Resveratrol (t-Rev) Encapsulated with Self-Assembling Lecithin-based Mixed Polymeric Micelles (saLMPMs).
Li TP; Wong WP; Chen LC; Su CY; Chen LG; Liu DZ; Ho HO; Sheu MT
Sci Rep; 2017 Sep; 7(1):10674. PubMed ID: 28878397
[TBL] [Abstract][Full Text] [Related]
7. Physical characterization and in vivo pharmacokinetic study of self-assembling amphotericin B-loaded lecithin-based mixed polymeric micelles.
Chen YC; Su CY; Jhan HJ; Ho HO; Sheu MT
Int J Nanomedicine; 2015; 10():7265-74. PubMed ID: 26664117
[TBL] [Abstract][Full Text] [Related]
8. Oligochitosan-pluronic 127 conjugate for delivery of honokiol.
Song Z; Sun J; Deng P; Zhou F; Xu H; Wen Y; Teng F; Ge D; Feng R
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):740-750. PubMed ID: 29400085
[TBL] [Abstract][Full Text] [Related]
9. UPLC-MS/MS-ESI assay for simultaneous determination of magnolol and honokiol in rat plasma: application to pharmacokinetic study after administration emulsion of the isomer.
Sheng YL; Xu JH; Shi CH; Li W; Xu HY; Li N; Zhao YQ; Zhang XR
J Ethnopharmacol; 2014 Sep; 155(3):1568-74. PubMed ID: 25102243
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study.
Chen LC; Chen YC; Su CY; Hong CS; Ho HO; Sheu MT
Int J Nanomedicine; 2016; 11():1557-66. PubMed ID: 27143878
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of oral bioavailability of magnolol by encapsulation in mixed micelles containing pluronic F127 and L61.
Shen H; Liu S; Ding P; Wang L; Ju J; Liang G
J Pharm Pharmacol; 2018 Apr; 70(4):498-506. PubMed ID: 29433156
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus-loaded polymeric micelles with honokiol for oral delivery.
Li X; Hou X; Ding W; Cong S; Zhang Y; Chen M; Meng Y; Lei J; Liu Y; Li G
J Pharm Pharmacol; 2015 Dec; 67(12):1663-72. PubMed ID: 26454249
[TBL] [Abstract][Full Text] [Related]
13. Self-Assembling Lecithin-Based Mixed Polymeric Micelles for Nose to Brain Delivery of Clozapine: In-vivo Assessment of Drug Efficacy via Radiobiological Evaluation.
M Elsharkawy F; M Amin M; A Shamsel-Din H; Ibrahim W; Ibrahim AB; Sayed S
Int J Nanomedicine; 2023; 18():1577-1595. PubMed ID: 37007986
[TBL] [Abstract][Full Text] [Related]
14. Honokiol nanosuspensions: preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system.
Han M; Yu X; Guo Y; Wang Y; Kuang H; Wang X
Colloids Surf B Biointerfaces; 2014 Apr; 116():114-20. PubMed ID: 24448177
[TBL] [Abstract][Full Text] [Related]
15. Maximizing dermal targeting and minimizing transdermal penetration by magnolol/honokiol methoxylation.
Lin CF; Hwang TL; Al-Suwayeh SA; Huang YL; Hung YY; Fang JY
Int J Pharm; 2013 Mar; 445(1-2):153-62. PubMed ID: 23380623
[TBL] [Abstract][Full Text] [Related]
16. Mixed Pluronic/lecithin micelles formulation for oral bioavailability of candesartan cilexetil drug:
Mahajan H; Patel HS; Ray D; Aswal VK; Sharma RK; Tandel H
Drug Dev Ind Pharm; 2024 Jan; 50(1):23-35. PubMed ID: 38079333
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the bioavailability of magnolol in rabbits using melting solid dispersion with polyvinylpyrrolidone.
Lin SP; Hou YC; Liao TY; Tsai SY
Drug Dev Ind Pharm; 2014 Mar; 40(3):330-7. PubMed ID: 23369092
[TBL] [Abstract][Full Text] [Related]
18. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).
Godugu C; Doddapaneni R; Singh M
Colloids Surf B Biointerfaces; 2017 May; 153():208-219. PubMed ID: 28249200
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, bioavailability, and tissue distribution of magnolol following single and repeated dosing of magnolol to rats.
Lin SP; Tsai SY; Lee Chao PD; Chen YC; Hou YC
Planta Med; 2011 Nov; 77(16):1800-5. PubMed ID: 21638244
[TBL] [Abstract][Full Text] [Related]
20. Isolation of anti-Saprolegnia lignans from Magnolia officinalis and SAR evaluation of honokiol/magnolol analogs.
Hu Y; Shen Y; Tu X; Wu X; Wang GX; Ling F
Bioorg Med Chem Lett; 2019 Feb; 29(3):389-395. PubMed ID: 30579792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
